Novartis News - NVS

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ and Amex.
Monthly Subscription
for only
$48.99
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$60.99
Big Cap Pro
Monthly Subscription
for only
$47.31
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Novartis Ag NVS NYSE Ordinary Share US66987V1098
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.13 +0.15% 85.33 85.38 84.4544 84.65 85.2 15:59:58
more quote information »
Industry Sector
Drug Manufacturers - Major

Recent News

Date Time Source Heading
2/23/201803:02DJNGreek Parliament Approves Bribery and Price Fix Inquiry on..
2/22/201809:10DJNGreek Parliament Investigates Politicians in Novartis..
2/21/201803:02DJNNovartis Builds Up R&D -- WSJ
2/19/201807:31DJNCorrection to Novartis CEO story
2/18/201809:29DJNNovartis CEO Steers Drug Maker Back to R&D
2/14/201802:04DJNNovartis Gets Funds From Bill & Melinda Gates Foundation to..
2/10/201810:34DJNCorrection to Novartis Story on Friday
2/09/201819:22DJNNovartis Faces Investigation For Alleged Bribery In Greece
2/01/201816:05GLOBEAdvanced Accelerator Applications Announces Completion of..
1/25/201801:50DJNNovartis, Spark Reach Agreement for Vision Loss Gene Therapy
1/24/201806:44DJNNovartis's Sales, Profit Surpass Expectations -- Earnings..
1/24/201806:00DJNCorrection to Novartis Earnings Article
1/24/201802:30DJNCorrection to Novartis Earnings Article
1/24/201802:24DJNNovartis 4Q Profit Rises, Buoyed by Sales of New Drugs --..
1/24/201802:05DJNNovartis 4Q Profit Rises, Buoyed by Sales of New Drugs
1/05/201818:16DJNADRs End Higher; Embraer Trades Actively
12/15/201701:48DJNNovartis Oncology CEO Bruno Strigini to Retire
12/11/201711:03PRNUSNovartis drug crizanlizumab shown to prolong time to..
12/08/201711:09DJNRoche, Novartis's Italian Heads Risk Trial for Alleged..
12/07/201707:00GLOBEAdvanced Accelerator Applications Announces Commencement of..
12/05/201716:00GLOBEAdvanced Accelerator Applications Board of Directors..
11/29/201718:00DJNNew Migraine Drugs Show Promise in Race to Sell..
11/20/201702:33DJNNovartis Secures EU Approval for Tasigna Treatment in..
11/13/201704:35DJNNovartis Vision Drug Shows Positive Results in Phase 3..
11/01/201709:14PRNUSNovartis presents data at ASH for patients with serious..
10/30/201719:46DJNADRs End Mostly Higher; Advanced Accelerator Applications,..
10/30/201709:00DJNNovartis to Pay $3.9 Billion for Radio-Pharmaceuticals Firm..
10/30/201703:08DJNNovartis to Buy Advanced Accelerator Applications for $3.9..
10/25/201719:34DJNADRs End Lower
10/24/201702:05DJNNovartis 3Q Net Profit Rises as New Drugs Offset Generic..
10/23/201719:14DJNADRs End Lower; DBV Technologies Trades Actively
10/23/201711:26DJNCorrection to article on growth in 'branded generics'
10/23/201711:18DJNCorrection to Drug Makers Find 'Branded Generics' Are a..
10/23/201709:27DJNEuropean Corporate Roundup for Monday
10/23/201708:40DJNDrug Makers Find 'Branded Generics' Are a Source for Growth
10/23/201705:17DJNEuropean Corporate Roundup for Monday
10/23/201702:20DJNNovartis Melanoma Treatment Awarded FDA Breakthrough..
9/05/201703:02DJNNovartis CEO Ends Turbulent Tenure -- WSJ
9/04/201707:43DJNNovartis CEO to Step Down In January -- 3rd Update
9/04/201704:31DJNNovartis CEO to Step Down In January -- 2nd Update
9/04/201704:10DJNNovartis CEO to Step Down In January -- Update
9/04/201702:51DJNCorrection to Novartis CEO Joe Jimenez to Step Down in..
9/04/201702:13DJNNovartis CEO Joe Jimenez to Step Down in January
8/30/201718:49DJNADRs End Mostly Lower
8/30/201716:18DJNFDA Approves First Gene Therapy in U.S. -- 2nd Update
8/30/201712:50DJNFDA Approves First Gene Therapy in U.S. -- Update
8/30/201712:25DJNFDA Approves First Gene Therapy in U.S.
8/28/201718:32DJNADRs End Mostly Lower; Gold Companies Trade Actively
8/28/201712:26DJNThe Promising New Cancer Treatment Behind Gilead's $11..
8/28/201706:35DJNNovartis Sees Positive Phase III Results for Canakinumab
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.